Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tenjin

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Oncology Reports|August 19, 2000
Telomerase activity in gynecological tumorsM Sakamoto, T Toyoizumi, Y Kikuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1991
[Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group]K Noda, M Shiota, O Tanizawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Phase II study of 5-FU tablets in cancer of the uterine cervix]K Sekiba, A Yajima, Y Tenjin, et al.
Human Cell|March 1, 1991
[Establishment and characterization of endometrial undifferentiated carcinoma cell line (TMCC-2.U)]H Iwabuchi, H Nakaya, H Sakunaga, et al.
Human Cell|December 1, 1993
[Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line]H Sasa, K Ishii, J Hirata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1996
[CGH (comparative genomic hybridization)]M Sakamoto, H Sakamoto, Y Suehiro, et al.
Human Cell|December 1, 1992
[Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines]H Sasa, Y Kikuchi, A Hisano, et al.
Diagnostic and Therapeutic Endoscopy|May 22, 2008
Application of PDT for Uterine Cervical CancerT Muroya, K Kawasaki, Y Suehiro, et al.
Human Cell|April 3, 2002
Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarrayM Sakamoto, A Kondo, K Kawasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 3, 1998
[Cancer-associated gene abnormalities and chemosensitivity]M Sakamoto, K Umayahara, H Sakamoto, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Oncology Reports|August 19, 2000
Telomerase activity in gynecological tumorsM Sakamoto, T Toyoizumi, Y Kikuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1991
[Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group]K Noda, M Shiota, O Tanizawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1987
[Phase II study of 5-FU tablets in cancer of the uterine cervix]K Sekiba, A Yajima, Y Tenjin, et al.
Human Cell|March 1, 1991
[Establishment and characterization of endometrial undifferentiated carcinoma cell line (TMCC-2.U)]H Iwabuchi, H Nakaya, H Sakunaga, et al.
Human Cell|December 1, 1993
[Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line]H Sasa, K Ishii, J Hirata, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1996
[CGH (comparative genomic hybridization)]M Sakamoto, H Sakamoto, Y Suehiro, et al.
Human Cell|December 1, 1992
[Cytokinetic effects of cisplatin on cisplatin-resistant ovarian cancer cell lines]H Sasa, Y Kikuchi, A Hisano, et al.
Diagnostic and Therapeutic Endoscopy|May 22, 2008
Application of PDT for Uterine Cervical CancerT Muroya, K Kawasaki, Y Suehiro, et al.
Human Cell|April 3, 2002
Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarrayM Sakamoto, A Kondo, K Kawasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 3, 1998
[Cancer-associated gene abnormalities and chemosensitivity]M Sakamoto, K Umayahara, H Sakamoto, et al.
Pageof 5